With the analysis among 204,812 patents, we discovered top 470 key players by total patent application. Novartis AG, F. Hoffmann-La Roche Ltd., AstraZeneca Pharmaceutical Co., Ltd. are dominant in this area. They take 4.65% of the total patent filing.
Basel-Stadt, Switzerland
Patent: 4,429
F. Hoffmann-La Roche Ltd.
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 2,008
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 1,954
Antwerpen, Belgium
Patent: 1,877
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 1,712
New York, United States
Patent: 1,596
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 1,549
California, United States
Patent: 1,401
New York, United States
Patent: 1,373
With the analysis among 8,105 patents, we discovered top 385 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, DRAGONFLY Therapeutics, Inc., Synthorx, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 343
California, United States
Patent: 141
Telangana, India
Patent: 131
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 127
Utrecht, Netherlands
Patent: 99
Prilenia Therapeutics Development Ltd.
Herefordshire, United Kingdom
Patent: 69
NiKang Therapeutics, Inc.
Delaware, United States
Patent: 53
With the analysis among related 170,504 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Novartis AG, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Immatics Biotechnologies GmbH take 2.45% of patent filing during this period.
Basel-Stadt, Switzerland
Patent: 1,655
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 1,284
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 1,231
F. Hoffmann-La Roche Ltd.
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 887
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 858
California, United States
Patent: 780
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Jiangsu Sheng, China
Patent: 676
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 637
Indiana, United States
Patent: 626
With the analysis among related 170,504 patents in last 5 years, we discover 22 new entrants. DRAGONFLY Therapeutics, Inc., BicycleTx Ltd., Synthorx, Inc. are the most active new entrants in this area.
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 343
Cambridgeshire, United Kingdom
Patent: 162
California, United States
Patent: 141
Utrecht, Netherlands
Patent: 99
Suzhou Yasheng Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 95
Lentigen Technology, Inc.
Beijing Shi, China
Patent: 77
Aligos Therapeutics, Inc.
California, United States
Patent: 77
Ascentage Pharma Group Corp. Ltd.
Shanghai Shi, China
Patent: 76
With the analysis among 62,721 patents, we discovered top 335 universities and scientific research institutions by total patent application. China Pharmaceutical University, Shanghai Institute of Materia Medica Chinese Academy of Sciences, Zhejiang University are dominant in this area. They take 4.74% of the total patent filing.
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 968
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 761
Zhejiang Sheng, China
Patent: 754
Guangdong Sheng, China
Patent: 690
Shanghai Shi, China
Patent: 654
Sichuan Sheng, China
Patent: 522
Chinese Academy of Medical Scciences & Peking Union Medical College
Shenyang Pharmaceutical University
Liaoning Sheng, China
Patent: 516
Jiangsu Sheng, China
Patent: 481
Academy of Military Medical Sciences